Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)
Bloomberg Intelligence24 Aug 2016

Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.

See omnystudio.com/listener for privacy information.

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
svd-ledarredaktionen
uppgang-och-fall
rss-borsens-finest
affarsvarlden
avanzapodden
lastbilspodden
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
borsmorgon
rss-inga-dumma-fragor-om-pengar
rss-en-rik-historia
tabberaset
kapitalet-en-podd-om-ekonomi
24fragor
fill-or-kill
market-makers
rss-veckans-trade